The DOI matches its Crossref record; 244 of the 244 references it cites were found in a registry or an index.
Idiopathic Pulmonary Fibrosis and Lung Cancer: Mechanisms and Molecular Targets
Open accessAbstract
Idiopathic pulmonary fibrosis (IPF) is the most common idiopathic interstitial pulmonary disease with a median survival of 2–4 years after diagnosis. A significant number of IPF patients have risk factors, such as a history of smoking or concomitant emphysema, both of which can predispose the patient to lung cancer (LC) (mostly non-small cell lung cancer (NSCLC)). In fact, IPF itself increases the risk of LC development by 7% to 20%. In this regard, there are multiple common genetic, molecular, and cellular processes that connect lung fibrosis with LC, such as myofibroblast/mesenchymal transition, myofibroblast activation and uncontrolled proliferation, endoplasmic reticulum stress, alterations of growth factors expression, oxidative stress, and large genetic and epigenetic variations that can predispose the patient to develop IPF and LC. The current approved IPF therapies, pirfenidone and nintedanib, are also active in LC. In fact, nintedanib is approved as a second line treatment in NSCLC, and pirfenidone has shown anti-neoplastic effects in preclinical studies. In this review, we focus on the current knowledge on the mechanisms implicated in the development of LC in patients with IPF as well as in current IPF and LC-IPF candidate therapies based on novel molecular advances.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED: TGF-β1 induces alveolar epithelial to mesenchymal transition in vitro
Yao, H.-W., Xie, Q.-M., Chen, J., Deng, Y., & Tang, H. (2004) · Life Sciences · doi:10.1016/j.lfs.2004.06.019 · Cited by 109
RetractedHallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D. M., Forman, D., & Bray, F. (2015) · International Journal of Cancer · doi:10.1002/ijc.29210 · Cited by 28,766
The basics of epithelial-mesenchymal transition
Kalluri, R., & Weinberg, R. A. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39104 · Cited by 10,196
Raghu, G., Collard, H. R., Egan, J. J., Martinez, F. J., Behr, J., Brown, K. K., Colby, T. V., Cordier, J.-F., Flaherty, K. R., Lasky, J. A., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2009-040gl · Cited by 7,186
Protective and pathogenic functions of macrophage subsets
Murray, P. J., & Wynn, T. A. (2011) · Nature Reviews Immunology · doi:10.1038/nri3073 · Cited by 5,269
The biology and function of fibroblasts in cancer
Kalluri, R. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.73 · Cited by 4,366
Tumor-Associated Macrophages: From Mechanisms to Therapy
Noy, R., & Pollard, J. W. (2014) · Immunity · doi:10.1016/j.immuni.2014.06.010 · Cited by 4,089
Levy, J. M. M., Towers, C. G., & Thorburn, A. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2017.53 · Cited by 2,526 · cited 1×
“Therefore, therapeutic targeting of autophagy in cancer is sometimes viewed as controversial [78].”
BackgroundLung Cancer: Epidemiology, Etiology, and Prevention
Dela Cruz, C. S., Tanoue, L. T., & Matthay, R. A. (2011) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2011.09.001 · Cited by 2,484
Self-consumption: the interplay of autophagy and apoptosis
Mariño, G., Niso-Santano, M., Baehrecke, E. H., & Kroemer, G. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3735 · Cited by 2,172
Lederer, D. J., & Martinez, F. J. (2018) · New England Journal of Medicine · doi:10.1056/nejmra1705751 · Cited by 2,056 · cited 1×
“Concurrently, there is evidence that galectin 3 is a promising target for IPF [158] because it has a profibrotic action [159] that is partly mediated by binding to Muc1 [160].”
BackgroundNon-small-cell lung cancers: a heterogeneous set of diseases
Chen, Z., Fillmore, C. M., Hammerman, P. S., Kim, C. F., & Wong, K.-K. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3775 · Cited by 1,942
Clinical course and prediction of survival in idiopathic pulmonary fibrosis
Ley, B., Collard, H. R., & King, T. E. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201006-0894ci · Cited by 1,765
Krtolica, A., Parrinello, S., Lockett, S., Desprez, P.-Y., & Campisi, J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.211053698 · Cited by 1,730
Zhu, Z., Homer, R. J., Wang, Z., Chen, Q., Geba, G. P., Wang, J., Zhang, Y., & Elias, J. A. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5909 · Cited by 1,719
Prednisone, Azathioprine, and N -Acetylcysteine for Pulmonary Fibrosis
The Idiopathic Pulmonary Fibrosis Clinical Research Network (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1113354 · Cited by 1,621
Cellular senescence mediates fibrotic pulmonary disease
Schafer, M. J., White, T. A., Iijima, K., Haak, A. J., Ligresti, G., Atkinson, E. J., Oberg, A. L., Birch, J., Salmonowicz, H., Zhu, Y., et al. (2017) · Nature Communications · doi:10.1038/ncomms14532 · Cited by 1,613 · cited 1×
“Analyses of cell types in the lungs of both human IPF and the bleomycin-injured mouse model have demonstrated that fibroblasts and epithelial cells acquire senescent identities [89].”
BackgroundTargeting the TGFβ signalling pathway in disease
Akhurst, R. J., & Hata, A. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3810 · Cited by 1,466
Telomerase Mutations in Families with Idiopathic Pulmonary Fibrosis
Armanios, M. Y., Chen, J. J.-L., Cogan, J. D., Alder, J. K., Ingersoll, R. G., Markin, C., Lawson, W. E., Xie, M., Vulto, I., Phillips, J. A., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066157 · Cited by 1,357
The role for autophagy in cancer
White, E. (2015) · Journal of Clinical Investigation · doi:10.1172/jci73941 · Cited by 1,332
A Common MUC5B Promoter Polymorphism and Pulmonary Fibrosis
Seibold, M. A., Wise, A. L., Speer, M. C., Steele, M. P., Brown, K. K., Loyd, J. E., Fingerlin, T. E., Zhang, W., Gudmundsson, G., Groshong, S. D., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1013660 · Cited by 1,198
Genomic Landscape of Non-Small Cell Lung Cancer in Smokers and Never-Smokers
Govindan, R., Ding, L., Griffith, M., Subramanian, J., Dees, N. D., Kanchi, K. L., Maher, C. A., Fulton, R., Fulton, L., Wallis, J., et al. (2012) · Cell · doi:10.1016/j.cell.2012.08.024 · Cited by 1,146
The antioxidant function of the p53 tumor suppressor
Sablina, A. A., Budanov, A. V., Ilyinskaya, G. V., Agapova, L. S., Kravchenko, J. E., & Chumakov, P. M. (2005) · Nature Medicine · doi:10.1038/nm1320 · Cited by 1,121
Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis
Phillips, R. J., Burdick, M. D., Hong, K., Lutz, M. A., Murray, L. A., Xue, Y. Y., Belperio, J. A., Keane, M. P., & Strieter, R. M. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420997 · Cited by 1,079
Role of Tyrosine Kinase Inhibitors in Cancer Therapy
Arora, A., & Scholar, E. M. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.084145 · Cited by 1,014
Discovery of Endothelial to Mesenchymal Transition as a Source for Carcinoma-Associated Fibroblasts
Zeisberg, E. M., Potenta, S., Xie, L., Zeisberg, M., & Kalluri, R. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-3127 · Cited by 1,011
Reck, M., Kaiser, R., Mellemgaard, A., Douillard, J.-Y., Orlov, S., Krzakowski, M., von Pawel, J., Gottfried, M., Bondarenko, I., Liao, M., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70586-2 · Cited by 951
Willis, B. C., Liebler, J. M., Luby-Phelps, K., Nicholson, A. G., Crandall, E. D., du Bois, R. M., & Borok, Z. (2005) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)62351-6 · Cited by 951
Adult-onset pulmonary fibrosis caused by mutations in telomerase
Tsakiri, K. D., Cronkhite, J. T., Kuan, P. J., Xing, C., Raghu, G., Weissler, J. C., Rosenblatt, R. L., Shay, J. W., & Garcia, C. K. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701009104 · Cited by 894 · cited 3×
“Furthermore, the germline variant, rs2736100, has been reported to be associated with lung ADC risk [205], and other TERT, TERC, OFBC1, and RTEL1 polymorphisms have also been revealed as risk factors of LC [206,207].”
Backgroundc-Myc Can Induce DNA Damage, Increase Reactive Oxygen Species, and Mitigate p53 Function
Vafa, O., Wade, M., Kern, S., Beeche, M., Pandita, T. K., Hampton, G. M., & Wahl, G. M. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00520-8 · Cited by 876
Antioxidants Accelerate Lung Cancer Progression in Mice
Sayin, V. I., Ibrahim, M. X., Larsson, E., Nilsson, J. A., Lindahl, P., & Bergo, M. O. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3007653 · Cited by 867
Pathogenesis of Idiopathic Pulmonary Fibrosis
Wolters, P. J., Collard, H. R., & Jones, K. D. (2014) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-012513-104706 · Cited by 862
Control of TH2 polarization by the chemokine monocyte chemoattractant protein-1
Gu, L., Tseng, S., Horner, R. M., Tam, C., Loda, M., & Rollins, B. J. (2000) · Nature · doi:10.1038/35006097 · Cited by 832
Tager, A. M., LaCamera, P., Shea, B. S., Campanella, G. S., Selman, M., Zhao, Z., Polosukhin, V., Wain, J., Karimi-Shah, B. A., Kim, N. D., et al. (2008) · Nature Medicine · doi:10.1038/nm1685 · Cited by 823
Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis
Fingerlin, T. E., Murphy, E., Zhang, W., Peljto, A. L., Brown, K. K., Steele, M. P., Loyd, J. E., Cosgrove, G. P., Lynch, D., Groshong, S., et al. (2013) · Nature Genetics · doi:10.1038/ng.2609 · Cited by 809
Mechanisms of Pulmonary Fibrosis
Thannickal, V. J., Toews, G. B., White, E. S., Lynch III, J. P., & Martinez, F. J. (2004) · Annual Review of Medicine · doi:10.1146/annurev.med.55.091902.103810 · Cited by 808
Endoplasmic Reticulum Stress in Disease Pathogenesis
Lin, J. H., Walter, P., & Yen, T. S. B. (2008) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathmechdis.3.121806.151434 · Cited by 807
Cancer-Associated Fibroblasts: Their Characteristics and Their Roles in Tumor Growth
Shiga, K., Hara, M., Nagasaki, T., Sato, T., Takahashi, H., & Takeyama, H. (2015) · Cancers · doi:10.3390/cancers7040902 · Cited by 774
Regulation of PDGF and its receptors in fibrotic diseases
Bonner, J. C. (2004) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2004.03.006 · Cited by 768
The two faces of transforming growth factor β in carcinogenesis
Roberts, A. B., & Wakefield, L. M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1633291100 · Cited by 747
TGF-β1 induces human alveolar epithelial to mesenchymal cell transition (EMT)
Kasai, H., Allen, J. T., Mason, R. M., Kamimura, T., & Zhang, Z. (2005) · Respiratory Research · doi:10.1186/1465-9921-6-56 · Cited by 744
Battegay, E. J., Raines, E. W., Seifert, R. A., Bowen-Pope, D. F., & Ross, R. (1990) · Cell · doi:10.1016/0092-8674(90)90448-n · Cited by 741
SpiroMeta Consortium, McKay, J. D., Hung, R. J., Han, Y., Zong, X., Carreras-Torres, R., Christiani, D. C., Caporaso, N. E., Johansson, M., Xiao, X., et al. (2017) · Nature Genetics · doi:10.1038/ng.3892 · Cited by 720
Aberrant Wnt/β-Catenin Pathway Activation in Idiopathic Pulmonary Fibrosis
Chilosi, M., Poletti, V., Zamò, A., Lestani, M., Montagna, L., Piccoli, P., Pedron, S., Bertaso, M., Scarpa, A., Murer, B., et al. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64282-4 · Cited by 708
DPC4 gene in various tumor types.
Schutte, M. E. M., Hruban, R. H., Hedrick, L., Cho, K. R., Nadasdy, G. M., Weinstein, C. L., Bova, G. S., Isaacs, W. B., Cairns, P., Nawroz, H., et al. (1996) · PubMed · Cited by 672
Wnt Signaling Pathway in Non-Small Cell Lung Cancer
Stewart, D. J. (2014) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djt356 · Cited by 651
Identification of Circulating Fibrocytes as Precursors of Bronchial Myofibroblasts in Asthma
Schmidt, M., Sun, G., Stacey, M. A., Mori, L., & Mattoli, S. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.1.380 · Cited by 643
Lung Cancer and Cryptogenic Fibrosing Alveolitis: A Population-based Cohort Study
HUBBARD, R., VENN, A., LEWIS, S., & BRITTON, J. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.1.9906062 · Cited by 639
Wollin, L., Maillet, I., Quesniaux, V., Holweg, A., & Ryffel, B. (2014) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.113.208223 · Cited by 633
Noth, I., Zhang, Y., Ma, S.-F., Flores, C., Barber, M., Huang, Y., Broderick, S. M., Wade, M. S., Hysi, P., Scuirba, J., et al. (2013) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(13)70045-6 · Cited by 614
Molecular Targets in Pulmonary Fibrosis
Scotton, C. J., & Chambers, R. C. (2007) · Chest · doi:10.1378/chest.06-2568 · Cited by 538
Butts, C., Socinski, M. A., Mitchell, P. L., Thatcher, N., Havel, L., Krzakowski, M., Nawrocki, S., Ciuleanu, T.-E., Bosquée, L., Trigo, J. M., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70510-2 · Cited by 538
Bone marrow contribution to tumor-associated myofibroblasts and fibroblasts
Direkze, N. C., Hodivala-Dilke, K., Jeffery, R., Hunt, T., Poulsom, R., Oukrif, D., Alison, M. R., & Wright, N. A. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1708 · Cited by 530
Regulation of Transforming Growth Factor-β1–driven Lung Fibrosis by Galectin-3
MacKinnon, A. C., Gibbons, M. A., Farnworth, S. L., Leffler, H., Nilsson, U. J., Delaine, T., Simpson, A. J., Forbes, S. J., Hirani, N., Gauldie, J., et al. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201106-0965oc · Cited by 516
Matrix Metalloproteinases as Therapeutic Targets for Idiopathic Pulmonary Fibrosis
Craig, V. J., Zhang, L., Hagood, J. S., & Owen, C. A. (2015) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2015-0020tr · Cited by 507
Randomized Trial of Acetylcysteine in Idiopathic Pulmonary Fibrosis
The Idiopathic Pulmonary Fibrosis Clinical Research Network (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1401739 · Cited by 505
Landi, M. T., Chatterjee, N., Yu, K., Goldin, L. R., Goldstein, A. M., Rotunno, M., Mirabello, L., Jacobs, K., Wheeler, W., Yeager, M., et al. (2011) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.05.003 · Cited by 496
Genetic Defects in Surfactant Protein A2 Are Associated with Pulmonary Fibrosis and Lung Cancer
Wang, Y., Kuan, P. J., Xing, C., Cronkhite, J. T., Torres, F., Rosenblatt, R. L., DiMaio, J. M., Kinch, L. N., Grishin, N. V., & Garcia, C. K. (2009) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2008.11.010 · Cited by 496
Landi, M. T., Chatterjee, N., Yu, K., Goldin, L. R., Goldstein, A. M., Rotunno, M., Mirabello, L., Jacobs, K., Wheeler, W., Yeager, M., et al. (2009) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2009.09.012 · Cited by 495
Telomere Dysfunction: A Potential Cancer Predisposition Factor
Wu, X., Amos, C. I., Zhu, Y., Zhao, H., Grossman, B. H., Shay, J. W., Luo, S., Hong, W. K., & Spitz, M. R. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djg011 · Cited by 494
Stuart, B. D., Choi, J., Zaidi, S., Xing, C., Holohan, B., Chen, R., Choi, M., Dharwadkar, P., Torres, F., Girod, C. E., et al. (2015) · Nature Genetics · doi:10.1038/ng.3278 · Cited by 469
Idiopathic pulmonary fibrosis: a disease with similarities and links to cancer biology
Vancheri, C., Failla, M., Crimi, N., & Raghu, G. (2010) · European Respiratory Journal · doi:10.1183/09031936.00077309 · Cited by 464
Targeting PI3K/AKT/mTOR pathway in non small cell lung cancer
Fumarola, C., Bonelli, M. A., Petronini, P. G., & Alfieri, R. R. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.05.011 · Cited by 463
Selman, M., & Pardo, A. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201312-2221pp · Cited by 454
Peljto, A. L., Zhang, Y., Fingerlin, T. E., Ma, S.-F., Garcia, J. G. N., Richards, T. J., Silveira, L. J., Lindell, K. O., Steele, M. P., Loyd, J. E., et al. (2013) · JAMA · doi:10.1001/jama.2013.5827 · Cited by 453
New cellular and molecular mechanisms of lung injury and fibrosis in idiopathic pulmonary fibrosis
Fernandez, I. E., & Eickelberg, O. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61144-1 · Cited by 437
Oku, H., Shimizu, T., Kawabata, T., Nagira, M., Hikita, I., Ueyama, A., Matsushima, S., Torii, M., & Arimura, A. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.06.046 · Cited by 436
Lawson, W. E., Crossno, P. F., Polosukhin, V. V., Roldan, J., Cheng, D.-S., Lane, K. B., Blackwell, T. R., Xu, C., Markin, C., Ware, L. B., et al. (2008) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00382.2007 · Cited by 429
Pericyte–fibroblast transition promotes tumor growth and metastasis
Hosaka, K., Yang, Y., Seki, T., Fischer, C., Dubey, O., Fredlund, E., Hartman, J., Religa, P., Morikawa, H., Ishii, Y., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1608384113 · Cited by 415
Utility of KL-6/MUC1 in the clinical management of interstitial lung diseases
Ishikawa, N., Hattori, N., Yokoyama, A., & Kohno, N. (2012) · Respiratory Investigation · doi:10.1016/j.resinv.2012.02.001 · Cited by 402
Emerging therapies for idiopathic pulmonary fibrosis, a progressive age-related disease
Mora, A. L., Rojas, M., Pardo, A., & Selman, M. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.170 · Cited by 402
Inhibition of platelet-derived growth factor signaling attenuates pulmonary fibrosis
Abdollahi, A., Li, M., Ping, G., Plathow, C., Domhan, S., Kiessling, F., Lee, L. B., McMahon, G., Gröne, H.-J., Lipson, K. E., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041393 · Cited by 388
Alterations of the Notch pathway in lung cancer
Westhoff, B., Colaluca, I. N., D'Ario, G., Donzelli, M., Tosoni, D., Volorio, S., Pelosi, G., Spaggiari, L., Mazzarol, G., Viale, G., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0907781106 · Cited by 387
Inhibition of PDGF, VEGF and FGF signalling attenuates fibrosis
Chaudhary, N. I., Roth, G. J., Hilberg, F., Müller-Quernheim, J., Prasse, A., Zissel, G., Schnapp, A., & Park, J. E. (2007) · European Respiratory Journal · doi:10.1183/09031936.00152106 · Cited by 386
Role of Lung Pericytes and Resident Fibroblasts in the Pathogenesis of Pulmonary Fibrosis
Hung, C., Linn, G., Chow, Y.-H., Kobayashi, A., Mittelsteadt, K., Altemeier, W. A., Gharib, S. A., Schnapp, L. M., & Duffield, J. S. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201212-2297oc · Cited by 385
Telomere Dysfunction Increases Mutation Rate and Genomic Instability
Hackett, J. A., Feldser, D. M., & Greider, C. W. (2001) · Cell · doi:10.1016/s0092-8674(01)00457-3 · Cited by 383
Macrophages: friend or foe in idiopathic pulmonary fibrosis?
Zhang, L., Wang, Y., Wu, G., Xiong, W., Gu, W., & Wang, C.-Y. (2018) · Respiratory Research · doi:10.1186/s12931-018-0864-2 · Cited by 375
Imatinib Treatment for Idiopathic Pulmonary Fibrosis: Randomized Placebo-controlled Trial Results
Daniels, C. E., Lasky, J. A., Limper, A. H., Mieras, K., Gabor, E., & Schroeder, D. R. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200906-0964oc · Cited by 373
Autophagy in Idiopathic Pulmonary Fibrosis
Patel, A. S., Lin, L., Geyer, A., Haspel, J. A., An, C. H., Cao, J., Rosas, I. O., & Morse, D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041394 · Cited by 372
IL-13 Activates a Mechanism of Tissue Fibrosis That Is Completely TGF-β Independent
Kaviratne, M., Hesse, M., Leusink, M., Cheever, A. W., Davies, S. J., McKerrow, J. H., Wakefield, L. M., Letterio, J. J., & Wynn, T. A. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.6.4020 · Cited by 370
Evolving Concepts of Apoptosis in Idiopathic Pulmonary Fibrosis
Thannickal, V. J., & Horowitz, J. C. (2006) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200601-001tk · Cited by 364
Ramos, C., Montaño, M., Garcı́a-Alvarez, J., Ruiz, V., Uhal, B. D., Selman, M., & Pardo, A. (2001) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.24.5.4333 · Cited by 363
Bafna, S., Kaur, S., & Batra, S. K. (2010) · Oncogene · doi:10.1038/onc.2010.87 · Cited by 360
Oldham, J. M., Ma, S.-F., Martinez, F. J., Anstrom, K. J., Raghu, G., Schwartz, D. A., Valenzi, E., Witt, L., Lee, C., Vij, R., et al. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201505-1010oc · Cited by 341 · cited 1×
“Following this, NAC monotherapy results were also negative [225], although a subgroup of IPF patients with the rs3750920 (TOLLIP) TT genotype showed a favourable response [226].”
ResultIdiopathic Pulmonary Fibrosis: Aberrant Recapitulation of Developmental Programs?
Selman, M., Pardo, A., & Kaminski, N. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050062 · Cited by 336
Insufficient autophagy in idiopathic pulmonary fibrosis
Araya, J., Kojima, J., Takasaka, N., Ito, S., Fujii, S., Hara, H., Yanagisawa, H., Kobayashi, K., Tsurushige, C., Kawaishi, M., et al. (2013) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00213.2012 · Cited by 325
Cumulative incidence of and predictive factors for lung cancer in IPF
OZAWA, Y., SUDA, T., NAITO, T., ENOMOTO, N., HASHIMOTO, D., FUJISAWA, T., NAKAMURA, Y., INUI, N., NAKAMURA, H., & CHIDA, K. (2009) · Respirology · doi:10.1111/j.1440-1843.2009.01547.x · Cited by 314
The Impact of Lung Cancer on Survival of Idiopathic Pulmonary Fibrosis
Tomassetti, S., Gurioli, C., Ryu, J. H., Decker, P. A., Ravaglia, C., Tantalocco, P., Buccioli, M., Piciucchi, S., Sverzellati, N., Dubini, A., et al. (2015) · Chest · doi:10.1378/chest.14-0359 · Cited by 314
What has senescence got to do with cancer?
Dimri, G. P. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.05.025 · Cited by 313
Barron, L., & Wynn, T. A. (2011) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00414.2010 · Cited by 304
The incidence of cancer in patients with idiopathic pulmonary fibrosis and sarcoidosis in the UK
Le Jeune, I., Gribbin, J., West, J., Smith, C., Cullinan, P., & Hubbard, R. (2007) · Respiratory Medicine · doi:10.1016/j.rmed.2007.07.012 · Cited by 296
Production of Interleukin 13 by Alveolar Macrophages from Normal and Fibrotic Lung
Hancock, A., Armstrong, L., Gama, R., & Millar, A. (1998) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.18.1.2627 · Cited by 275
The Unfolded Protein Response, Degradation from the Endoplasmic Reticulum, and Cancer
Tsai, Y. C., & Weissman, A. M. (2010) · Genes & Cancer · doi:10.1177/1947601910383011 · Cited by 267
Lung cancer in patients with idiopathic pulmonary fibrosis
Park, J., Kim, D. S., Shim, T. S., Lim, C.-M., Koh, Y., Lee, S. D., Kim, W. S., Kim, W. D., Lee, J. S., & Song, K. S. (2001) · European Respiratory Journal · doi:10.1183/09031936.01.99055301 · Cited by 267
Human non-small cell lung cancer cells express a type 2 cytokine pattern
(1996) · Lung Cancer · doi:10.1016/0169-5002(96)85851-x · Cited by 257
Mulugeta, S., Nguyen, V., Russo, S. J., Muniswamy, M., & Beers, M. F. (2005) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2005-0009oc · Cited by 257
HSP27 and HSP70: Potentially Oncogenic Apoptosis Inhibitors
Garrido, C., Schmitt, E., Candé, C., Vahsen, N., Parcellier, A., & Kroemer, G. (2003) · Cell Cycle · doi:10.4161/cc.2.6.521 · Cited by 252
Deletions of 17p and p53 mutations in preneoplastic lesions of the lung.
Sozzi, G., Miozzo, M. R., Donghi, R., Pilotti, S., Cariani, C. T., Pastorino, U., Porta, G., & Pierotti, M. A. (1992) · PubMed · Cited by 250
An Exome Sequencing Study to Assess the Role of Rare Genetic Variation in Pulmonary Fibrosis
Petrovski, S., Todd, J. L., Durheim, M. T., Wang, Q., Chien, J. W., Kelly, F. L., Frankel, C., Mebane, C. M., Ren, Z., Bridgers, J., et al. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201610-2088oc · Cited by 242
Horowitz, J. C., Lee, D. Y., Waghray, M., Keshamouni, V. G., Thomas, P. E., Zhang, H., Cui, Z., & Thannickal, V. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m306248200 · Cited by 239 · cited 9×
“In fact, overexpression of class I isoform p110γ in lung homogenates occurs in IPF patients [173], and has been shown to activate the downstream signalling of several key profibrotic growth factors implicated in IPF, including PDGF and TGFβ1 [174,175], as well as abnormal proliferation of epithelial basal cells [173]…”
InfluentialTanjore, H., Blackwell, T. S., & Lawson, W. E. (2012) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00410.2011 · Cited by 236
Fibrocytes: a unique cell population implicated in wound healing
Metz, C. N. (2003) · Cellular and Molecular Life Sciences CMLS · doi:10.1007/s00018-003-2328-0 · Cited by 235
Thy-1 Promoter Hypermethylation: A Novel Epigenetic Pathogenic Mechanism in Pulmonary Fibrosis
Sanders, Y. Y., Pardo, A., Selman, M., Nuovo, G. J., Tollefsbol, T. O., Siegal, G. P., & Hagood, J. S. (2008) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2007-0322oc · Cited by 235
VEGF as a potential target in lung cancer
Frezzetti, D., Gallo, M., Maiello, M. R., D’Alessio, A., Esposito, C., Chicchinelli, N., Normanno, N., & De Luca, A. (2017) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2017.1371137 · Cited by 235
Imatinib as a Novel Antifibrotic Agent in Bleomycin-induced Pulmonary Fibrosis in Mice
Aono, Y., Nishioka, Y., Inayama, M., Ugai, M., Kishi, J., Uehara, H., Izumi, K., & Sone, S. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200404-531oc · Cited by 231
Karachaliou, N., Mayo, C., Costa, C., Magrí, I., Gimenez-Capitan, A., Molina-Vila, M. A., & Rosell, R. (2013) · Clinical Lung Cancer · doi:10.1016/j.cllc.2012.09.007 · Cited by 228
Yang, M., Shen, H., Qiu, C., Ni, Y., Wang, L., Dong, W., Liao, Y., & Du, J. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2012.09.031 · Cited by 226
Zhang, S., Smartt, H. J. M., Holgate, S. T., & Roche, W. R. (1999) · PubMed · Cited by 218
p53 Protein accumulates frequently in early bronchial neoplasia
(1994) · Lung Cancer · doi:10.1016/0169-5002(94)90320-4 · Cited by 212
Farhad, M., Rolig, A. S., & Redmond, W. L. (2018) · OncoImmunology · doi:10.1080/2162402x.2018.1434467 · Cited by 212
Global Methylation Patterns in Idiopathic Pulmonary Fibrosis
Rabinovich, E. I., Kapetanaki, M. G., Steinfeld, I., Gibson, K. F., Pandit, K. V., Yu, G., Yakhini, Z., & Kaminski, N. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033770 · Cited by 197
The genetic basis of idiopathic pulmonary fibrosis
Kropski, J. A., Blackwell, T. S., & Loyd, J. E. (2015) · European Respiratory Journal · doi:10.1183/09031936.00163814 · Cited by 193
Rinkevich, Y., Mori, T., Sahoo, D., Xu, P.-X., Bermingham, J. R., & Weissman, I. L. (2012) · Nature Cell Biology · doi:10.1038/ncb2610 · Cited by 186
Hetzel, M., Bachem, M., Anders, D., Trischler, G., & Faehling, M. (2005) · Lung · doi:10.1007/s00408-004-2534-z · Cited by 186
The Role of the Mammalian Target of Rapamycin (mTOR) in Pulmonary Fibrosis
Lawrence, J., & Nho, R. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19030778 · Cited by 183
Khalil, N., Xu, Y. D., O'Connor, R., & Duronio, V. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m510441200 · Cited by 182
Allen, J. T., Knight, R. A., Bloor, C. A., & Spiteri, M. A. (1999) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.21.6.3719 · Cited by 180
Kang, J. U., Koo, S. H., Kwon, K. C., Park, J. W., & Kim, J. M. (2008) · Cancer Genetics and Cytogenetics · doi:10.1016/j.cancergencyto.2007.12.004 · Cited by 180
The MUC1 and Galectin-3 Oncoproteins Function in a MicroRNA-Dependent Regulatory Loop
Ramasamy, S., Duraisamy, S., Barbashov, S., Kawano, T., Kharbanda, S., & Kufe, D. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.07.031 · Cited by 180
How does comorbidity influence survival in idiopathic pulmonary fibrosis?
Hyldgaard, C., Hilberg, O., & Bendstrup, E. (2014) · Respiratory Medicine · doi:10.1016/j.rmed.2014.01.008 · Cited by 180
The role of tyrosine kinases in the pathogenesis of idiopathic pulmonary fibrosis
Grimminger, F., Günther, A., & Vancheri, C. (2015) · European Respiratory Journal · doi:10.1183/09031936.00149614 · Cited by 178
Deregulation of selective autophagy during aging and pulmonary fibrosis: the role of TGF β1
Sosulski, M. L., Gongora, R., Danchuk, S., Dong, C., Luo, F., & Sanchez, C. G. (2015) · Aging Cell · doi:10.1111/acel.12357 · Cited by 176
Independent prognostic value of fascin immunoreactivity in stage I nonsmall cell lung cancer
Pelosi, G., Pastorino, U., Pasini, F., Maissoneuve, P., Fraggetta, F., lannucci, A., Sonzogni, A., De Manzoni, G., Terzi, A., Durante, E., et al. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6600731 · Cited by 174
Langevin, S. M., Kratzke, R. A., & Kelsey, K. T. (2015) · Translational Research · doi:10.1016/j.trsl.2014.03.001 · Cited by 173
Connective Tissue Growth Factor and Its Role in Lung Adenocarcinoma Invasion and Metastasis
Chang, C.-C., Shih, J.-Y., Jeng, Y.-M., Su, J.-L., Lin, B.-Z., Chen, S.-T., Chau, Y.-P., Yang, P.-C., & Kuo, M.-L. (2004) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djh059 · Cited by 173
Lung cancer in patients with idiopathic pulmonary fibrosis
Karampitsakos, T., Tzilas, V., Tringidou, R., Steiropoulos, P., Aidinis, V., Papiris, S. A., Bouros, D., & Tzouvelekis, A. (2017) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2017.03.016 · Cited by 171
Re-evaluation of Fibrogenic Cytokines in Lung Fibrosis
Kelly, M., Kolb, M., Bonniaud, P., & Gauldie, J. (2003) · Current Pharmaceutical Design · doi:10.2174/1381612033392341 · Cited by 170
Maitra, M., Wang, Y., Gerard, R. D., Mendelson, C. R., & Garcia, C. K. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.121467 · Cited by 167
Common pathways in idiopathic pulmonary fibrosis and cancer
Vancheri, C. (2013) · European Respiratory Review · doi:10.1183/09059180.00003613 · Cited by 166
Soria, J.-C., Shepherd, F. A., Douillard, J.-Y., Wolf, J., Giaccone, G., Crino, L., Cappuzzo, F., Sharma, S., Gross, S. H., Dimitrijevic, S., et al. (2009) · Annals of Oncology · doi:10.1093/annonc/mdp060 · Cited by 163
Conte, E., Fruciano, M., Fagone, E., Gili, E., Caraci, F., Iemmolo, M., Crimi, N., & Vancheri, C. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024663 · Cited by 162
Primary Pulmonary Carcinoma in Patients With Idiopathic Pulmonary Fibrosis
Aubry, M.-C., Myers, J. L., Douglas, W. W., Tazelaar, H. D., Stephens, T. L. W., Hartman, T. E., Deschamps, C., & Pankratz, V. S. (2002) · Mayo Clinic Proceedings · doi:10.4065/77.8.763 · Cited by 161
Germline SFTPA1 mutation in familial idiopathic interstitial pneumonia and lung cancer
Nathan, N., Giraud, V., Picard, C., Nunès, H., Moal, F., Copin, B., Galeron, L., Ligniville, A. D., Kuziner, N., Reynaud‐Gaubert, M., et al. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw014 · Cited by 161
Growth factors in idiopathic pulmonary fibrosis: relative roles
Allen, J., & Spiteri, M. A. (2001) · Respiratory Research · doi:10.1186/rr162 · Cited by 160
The prevalence of pulmonary fibrosis combined with emphysema in patients with lung cancer
Usui, K., Tanai, C., Tanaka, Y., Noda, H., & Ishihara, T. (2010) · Respirology · doi:10.1111/j.1440-1843.2010.01907.x · Cited by 154
Expression and Localization of Lung Surfactant Protein A in Human Tissues
Madsen, J., Tornøe, I., Nielsen, O., Koch, C., Steinhilber, W., & Holmskov, U. (2003) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2002-0274oc · Cited by 154
Differential Proliferation of Fibroblasts Cultured from Normal and Fibrotic Human Lungs
Raghu, G., Chen, Y., Rusch, V. W., & Rabinovitch, P. S. (1988) · American Review of Respiratory Disease · doi:10.1164/ajrccm/138.3.703 · Cited by 147
Behr, J., Bendstrup, E., Crestani, B., Günther, A., Olschewski, H., Sköld, C. M., Wells, A., Wuyts, W., Koschel, D., Kreuter, M., et al. (2016) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(16)30044-3 · Cited by 146
Integrin α4β1 Regulates Migration across Basement Membranes by Lung Fibroblasts
White, E. S., Thannickal, V. J., Carskadon, S. L., Dickie, E. G., Livant, D. L., Markwart, S. M., Toews, G. B., & Arenberg, D. A. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200301-041oc · Cited by 145
Hisatomi, K., Mukae, H., Sakamoto, N., Ishimatsu, Y., Kakugawa, T., Hara, S., Fujita, H., Nakamichi, S., Oku, H., Urata, Y., et al. (2012) · BMC Pulmonary Medicine · doi:10.1186/1471-2466-12-24 · Cited by 144
The lysophosphatidic acid receptor LPA1 promotes epithelial cell apoptosis after lung injury
Funke, M., Zhao, Z., Xu, Y., Chun, J., & Tager, A. M. (2012) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2010-0155oc · Cited by 141
Cao, H., Wang, C., Chen, X., Hou, J., Xiang, Z., Shen, Y., & Han, X. (2018) · Scientific Reports · doi:10.1038/s41598-018-28968-9 · Cited by 141
BRAF Alterations as Therapeutic Targets in Non–Small-Cell Lung Cancer
Nguyen‐Ngoc, T., Bouchaab, H., Adjei, A. A., & Peters, S. (2015) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000644 · Cited by 140
Latest developments in MUC1 immunotherapy
Taylor‐Papadimitriou, J., Burchell, J., Graham, R. A., & Beatson, R. (2018) · Biochemical Society Transactions · doi:10.1042/bst20170400 · Cited by 138
Bleomycin-Induced E Prostanoid Receptor Changes Alter Fibroblast Responses to Prostaglandin E2
Moore, B. B., Ballinger, M. N., White, E. S., Green, M. E., Herrygers, A. B., Wilke, C. A., Toews, G. B., & Peters-Golden, M. L. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.9.5644 · Cited by 135
Lung, H. L., Bangarusamy, D., Xie, D., Cheung, A., Cheng, Y., Kumaran, M., Miller, L., Liu, E., Guan, X., Sham, J., et al. (2005) · Oncogene · doi:10.1038/sj.onc.1208812 · Cited by 135
Noskovičová, N., Petřek, M., Eickelberg, O., & Heinzelmann, K. (2014) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2014-0294tr · Cited by 131
Mediavilla-Varela, M., Boateng, K. A., Noyes, D. R., & Antonia, S. J. (2016) · BMC Cancer · doi:10.1186/s12885-016-2162-z · Cited by 131
Pathogenesis and Natural History of Usual Interstitial Pneumonia
Strieter, R. M. (2005) · CHEST Journal · doi:10.1378/chest.128.5_suppl_1.526s · Cited by 129
Zhang, C., Lan, T., Hou, J., Li, J., Fang, R., Yang, Z., Zhang, M., Liu, J., & Liu, B. (2014) · Oncotarget · doi:10.18632/oncotarget.2025 · Cited by 125
Stewart, G. A., Hoyne, G. F., Ahmad, S. A., Jarman, E., Wallace, W. A., Harrison, D. J., Haslett, C., Lamb, J. R., & Howie, S. (2003) · The Journal of Pathology · doi:10.1002/path.1295 · Cited by 125
Incidence and predictive factors of lung cancer in patients with idiopathic pulmonary fibrosis
Katô, E., Takayanagi, N., Takaku, Y., Kagiyama, N., Kanauchi, T., Ishiguro, T., & Sugita, Y. (2018) · ERJ Open Research · doi:10.1183/23120541.00111-2016 · Cited by 124
Erratum: Emerging therapies for idiopathic pulmonary fibrosis, a progressive age-related disease
Mora, A. L., Rojas, M., Pardo, A., & Selman, M. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.225 · Cited by 124
Lin, X., Yu, M., Wu, K., Yuan, H., & Zhong, H. (2009) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.08-2815 · Cited by 122
West Japan Oncology Group, Iwata, T., Yoshino, I., Yoshida, S., Ikeda, N., Tsuboi, M., Asato, Y., Katakami, N., Sakamoto, K., Yamashita, Y., et al. (2016) · Respiratory Research · doi:10.1186/s12931-016-0398-4 · Cited by 122
Battegay, E., Raines, E. W., Colbert, T., & Ross, R. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.11.6040 · Cited by 120
Osterholzer, J. J., Olszewski, M. A., Murdock, B. J., Chen, G.-H., Erb‐Downward, J. R., Subbotina, N., Browning, K., Lin, Y., Morey, R. E., Dayrit, J. K., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1200604 · Cited by 118
Lee, C. G., Kang, H.-R., Homer, R., Chupp, G. L., & Elias, J. A. (2006) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200602-017aw · Cited by 116
Nasreen, N., Mohammed, K. A., Mubarak, K. K., Baz, M. A., Akindipe, O., Fernández-Bussy, S., & Antony, V. B. (2009) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.90587.2008 · Cited by 116
Lung Cancer in Patients with Idiopathic Pulmonary Fibrosis.
Nagai, A., Chiyotani, A., Nakadate, T., & Konno, K. (1992) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.167.231 · Cited by 112
Hedgehog Signaling in Lung Cancer: From Oncogenesis to Cancer Treatment Resistance
Leprieur, E. G., Costantini, A., Ding, V. W., & He, B. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19092835 · Cited by 112
Gefitinib Prevents Bleomycin-induced Lung Fibrosis in Mice
Ishii, Y., Fujimoto, S., & Fukuda, T. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200509-1534oc · Cited by 111
Migratory marker expression in fibroblast foci of idiopathic pulmonary fibrosis
Chilosi, M., Zamò, A., Doglioni, C., Reghellin, D., Lestani, M., Montagna, L., Pedron, S., Ennas, M. G., Cancellieri, A., Murer, B., et al. (2006) · Respiratory Research · doi:10.1186/1465-9921-7-95 · Cited by 111
Saito, Y., Kawai, Y., Takahashi, N., Ikeya, T., Murai, K., Kawabata, Y., & Hoshi, E. (2011) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2011.06.055 · Cited by 110
Choi, K., Lee, K., Ryu, S., Im, M.-J., Kook, K. H., & Choi, C. (2012) · PubMed · Cited by 110
Shikada, Y., Yonemitsu, Y., Koga, T., Onimaru, M., Nakano, T., Okano, S., Sata, S., Nakagawa, K., Yoshino, I., Maehara, Y., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4171 · Cited by 105
Huang, S. K., Scruggs, A. M., McEachin, R. C., White, E. S., & Peters-Golden, M. L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0107055 · Cited by 104
Malouf, M. A., Hopkins, P. M.-A., Snell, G. I., & Glanville, A. R. (2011) · Respirology · doi:10.1111/j.1440-1843.2011.01955.x · Cited by 102
Conte, E., Gili, E., Fruciano, M., Korfei, M., Fagone, E., Iemmolo, M., Furno, D. L., Giuffrida, R., Crimi, N., Günther, A., et al. (2013) · Laboratory Investigation · doi:10.1038/labinvest.2013.6 · Cited by 100
Potent antioxidant role of Pirfenidone in experimental cirrhosis
Salazar-Montes, A., Ruiz-Corro, L., López-Reyes, A. G., Castrejón-Gómez, E., & Armendáriz‐Borunda, J. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.06.110 · Cited by 99
Lung cancer in idiopathic pulmonary fibrosis: A systematic review and meta-analysis
Jafarinezhad, A., & YektaKooshali, M. H. (2018) · PLoS ONE · doi:10.1371/journal.pone.0202360 · Cited by 97
Vancheri, C., Sortino, M. A., Tomaselli, V., Mastruzzo, C., Condorelli, F., Bellistrı́, G., Pistorio, M. P., Canonico, P. L., & Crimi, N. (2000) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.22.5.3948 · Cited by 96
Moshai, E. F., Wémeau-Stervinou, L., Cigna, N., Brayer, S., Marchal-Sommé, J., Crestani, B., & Mailleux, A. (2014) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2013-0154oc · Cited by 96
Nho, R. S., Hergert, P. J., Kahm, J., Jessurun, J., & Henke, C. A. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.07.020 · Cited by 96
SFTPA2 Mutations in Familial and Sporadic Idiopathic Interstitial Pneumonia
van Moorsel, C. H. M., ten Klooster, L., van Oosterhout, M. F. M., de Jong, P. A., Adams, H., van Es, H. W., Ruven, H. J. T., van der Vis, J. J., & Grutters, J. C. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201504-0675le · Cited by 93
Treatment and outcome of lung cancer in idiopathic interstitial pneumonias.
Kreuter, M., Ehlers-Tenenbaum, S., Schaaf, M., Oltmanns, U., Palmowski, K., Hoffmann, H., Schnabel, P. A., Heußel, C. P., Puderbach, M., Herth, F. J. F., et al. (2015) · Sarcoidosis vasculitis and diffuse lung diseases · Cited by 92
Cesen-Cummings, K., Fernstrom, M. J., Malkinson, A. M., & Ruch, R. J. (1998) · Carcinogenesis · doi:10.1093/carcin/19.1.61 · Cited by 92
Lovgren, A. K., Kovacs, J. J., Xie, T., Potts, E. N., Li, Y., Foster, W. M., Liang, J., Meltzer, E. B., Jiang, D., Lefkowitz, R. J., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3001564 · Cited by 90
Miura, Y., Saito, T., Tanaka, T., Takoi, H., Yatagai, Y., Inomata, M., Nei, T., Saito, Y., Gemma, A., & Azuma, A. (2017) · Respiratory Investigation · doi:10.1016/j.resinv.2017.09.007 · Cited by 90
Parenchymal trafficking of pleural mesothelial cells in idiopathic pulmonary fibrosis
Mubarak, K. K., Montes‐Worboys, A., Regev, D., Nasreen, N., Mohammed, K. A., Faruqi, I., Hensel, E., Baz, M. A., Akindipe, O., Fernández-Bussy, S., et al. (2011) · European Respiratory Journal · doi:10.1183/09031936.00141010 · Cited by 87
Mizushima, Y., & Kobayashi, M. (1995) · CHEST Journal · doi:10.1378/chest.108.5.1272 · Cited by 86
Pleural Mesothelial Cell Differentiation and Invasion in Fibrogenic Lung Injury
Zolak, J. S., JAGIRDAR, R. M., Surolia, R., Karki, S., Oliva, O., Hock, T., Guroji, P., Ding, Q., Liu, R.-M., Bolisetty, S., et al. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2012.12.030 · Cited by 85
Hironaka, M., & Fukayama, M. (1999) · Pathology International · doi:10.1046/j.1440-1827.1999.00989.x · Cited by 85
Ingram, J. L., Rice, A. B., Geisenhoffer, K., Madtes, D. K., & Bonner, J. C. (2004) · The FASEB Journal · doi:10.1096/fj.03-1492fje · Cited by 84
Effect of Nilotinib on Bleomycin-Induced Acute Lung Injury and Pulmonary Fibrosis in Mice
Rhee, C. K., Lee, S. H., Yoon, H. K., Kim, S. C., Lee, S. Y., Kwon, S. S., Kim, Y. K., Kim, K. H., Kim, T. J., & Kim, J. W. (2011) · Respiration · doi:10.1159/000327719 · Cited by 83
The mystery of let-7d – a small RNA with great power
Kolenda, T., Przybyła, W., Teresiak, A., Mackiewicz, A. A., & Lamperska, K. M. (2014) · Współczesna Onkologia · doi:10.5114/wo.2014.44467 · Cited by 82
Yoon, J. H., Nouraie, M. S., Chen, X., Zou, R. H., Sellarés, J., Veraldi, K. L., Chiarchiaro, J., Lindell, K. O., Wilson, D. O., Kaminski, N., et al. (2018) · Respiratory Research · doi:10.1186/s12931-018-0899-4 · Cited by 79
Kavanaugh, W. M., Klippel, A., Escobedo, J. A., & Williams, L. T. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.8.3415 · Cited by 77
Kawasaki, H., Nagai, K., Yokose, T., Yoshida, J., Nishimura, M., Takahashi, K., Suzuki, K., Kakinuma, R., & Nishiwaki, Y. (2001) · Journal of Surgical Oncology · doi:10.1002/1096-9098(200101)76:1<53::aid-jso1009>3.0.co;2-t · Cited by 77
Chen, X., Shi, C., Meng, X., Zhang, K., Li, X., Wang, C., Xiang, Z., Hu, K., & Han, X. (2016) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2016.04.003 · Cited by 77
Pulmonary fibrosis requires cell-autonomous mesenchymal fibroblast growth factor (FGF) signaling
Guzy, R. D., Li, L., Smith, C. R., Dorry, S. J., Koo, H. Y., Chen, L., & Ornitz, D. M. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.791764 · Cited by 76
Chung, L.-Y., Tang, S., Wu, Y.-C., Sun, G.-H., Liu, H.-Y., & Sun, K. (2014) · Oncotarget · doi:10.18632/oncotarget.3210 · Cited by 75
Notch3 overexpression associates with poor prognosis in human non-small-cell lung cancer
Ye, Y., Zhang, Z., Fan, X.-Y., Xu, X., Chen, M.-L., Chang, B., & Zhang, Y. (2013) · Medical Oncology · doi:10.1007/s12032-013-0595-7 · Cited by 73
Bai, X., Zhang, X., Yang, S., An, S., Chen, Z., Su, J., Xie, Z., Gou, L.-Y., & Wu, Y.-L. L. C. (2016) · PLoS ONE · doi:10.1371/journal.pone.0149370 · Cited by 72
Aberrations in the fragile histidine triad (FHIT) gene in idiopathic pulmonary fibrosis.
Uematsu, K., Yoshimura, A., Gemma, A., Mochimaru, H., Hosoya, Y., Kunugi, S., Matsuda, K., Seike, M., Kurimoto, F., Takenaka, K., et al. (2001) · PubMed · Cited by 68
Nuclear Factor–Erythroid-2–Related Factor 2 in Aging and Lung Fibrosis
Swamy, S., Rajasekaran, N. S., & Thannickal, V. J. (2016) · American Journal Of Pathology · doi:10.1016/j.ajpath.2016.02.022 · Cited by 67
Chien, W., Yin, D., Gui, D., Mori, A., Frank, J. M., SAID, J. W., Kusuanco, D. A., Marchevsky, A. M., McKenna, R. J., & Koeffler, H. P. (2006) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-06-0029 · Cited by 66
Salinaro, A. T., Salinaro, E. T., Failla, M., Mastruzzo, C., Tomaselli, V., Gili, E., Crimi, N., Condorelli, D. F., & Vancheri, C. (2006) · Respiratory Research · doi:10.1186/1465-9921-7-122 · Cited by 66
Ballinger, M. N., Newstead, M. W., Zeng, X., Bhan, U., Mo, X. M., Kunkel, S. L., Moore, B. B., Flavell, R. A., Christman, J. W., & Standiford, T. J. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1402377 · Cited by 65
Cited by
Oxidative Stress and Inflammation in Acute and Chronic Lung Injuries
Bezerra, F. S., Lanzetti, M., Nesi, R. T., Nagato, A. C., Silva, C. P. E., Kennedy-Feitosa, E., Melo, A. C., Cattani-Cavalieri, I., Porto, L. C., & Valenca, S. S. (2023) · Antioxidants · doi:10.3390/antiox12030548 · Cited by 336
Immune Checkpoint Inhibitor-Related Pneumonitis
Gomatou, G., Tzilas, V., Kotteas, E., Syrigos, K., & Bouros, D. (2020) · Respiration · doi:10.1159/000509941 · Cited by 75
The Hedgehog Signaling Pathway in Idiopathic Pulmonary Fibrosis: Resurrection Time
Effendi, W. I., & Nagano, T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010171 · Cited by 59
Radon Biomonitoring and microRNA in Lung Cancer
Bersimbaev, R., Pulliero, A., Bulgakova, O., Kussainova, A., Aripova, A., & Izzotti, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21062154 · Cited by 53
Luo, J., Zhang, T., Zhu, C., Sun, J., Zhu, W., Ai, W., Huang, X., & Wang, X. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15505 · Cited by 46
Metadata
- Authors
- Ballester, B., Milara, J., & Cortijo, J.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2019-01-30
- Volume
- 20
- Issue
- 3
- Pages
- 593
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W2913356394
- Cited by
- 308
- References
- 244
- FWCI
- 22.07
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.